Matsumoto T - Search Results

1

An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo.

Asano M, Yukita A, Matsumoto T, Hanatani M, Suzuki H. Asano M, et al. Among authors: matsumoto t. Hybridoma. 1998 Apr;17(2):185-90. doi: 10.1089/hyb.1998.17.185. Hybridoma. 1998. PMID: 9627059

2

Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.

Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H. Asano M, et al. Among authors: matsumoto t. Cancer Res. 1995 Nov 15;55(22):5296-301. Cancer Res. 1995. PMID: 7585591

3

Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121).

Asano M, Yukita A, Matsumoto T, Matsuo K, Kondo S, Suzuki H. Asano M, et al. Among authors: matsumoto t. Hybridoma. 1995 Oct;14(5):475-80. doi: 10.1089/hyb.1995.14.475. Hybridoma. 1995. PMID: 8575796

4

The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability.

Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H. Kondo S, et al. Among authors: matsumoto t. Biochim Biophys Acta. 1995 Feb 23;1243(2):195-202. doi: 10.1016/0304-4165(94)00150-v. Biochim Biophys Acta. 1995. PMID: 7533000

5

Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients.

Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T, Tominaga T. Yamamoto Y, et al. Among authors: matsumoto t. Clin Cancer Res. 1996 May;2(5):821-6. Clin Cancer Res. 1996. PMID: 9816236

6

Internal thoracic-carotid bypass surgery for Takayasu's arteritis.

Matsumoto T, Yamada K, Shimazu N, Mase M, Mishima A, Asano M, Ukai T, Narita H. Matsumoto T, et al. Surg Neurol. 1998 Apr;49(4):417-9. doi: 10.1016/s0090-3019(97)00307-8. Surg Neurol. 1998. PMID: 9537660

7

Survival analysis of platinum-refractory patients with advanced esophageal cancer treated with docetaxel or best supportive care alone: a retrospective study.

Moriwaki T, Kajiwara T, Matsumoto T, Suzuki H, Hiroshima Y, Matsuda K, Hirai S, Yamamoto Y, Yamada T, Sugaya A, Kobayashi M, Endo S, Ishige K, Nishina T, Hyodo I. Moriwaki T, et al. Among authors: matsumoto t. Dis Esophagus. 2014 Nov-Dec;27(8):737-43. doi: 10.1111/dote.12246. Epub 2014 Jun 11. Dis Esophagus. 2014. PMID: 24917486

8

A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.

Abe J, Nakano T, Nishii Y, Matsumoto T, Ogata E, Ikeda K. Abe J, et al. Among authors: matsumoto t. Endocrinology. 1991 Aug;129(2):832-7. doi: 10.1210/endo-129-2-832. Endocrinology. 1991. PMID: 1855478

9

Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24.

Ozaki S, Kosaka M, Wakatsuki S, Abe M, Koishihara Y, Matsumoto T. Ozaki S, et al. Among authors: matsumoto t. Blood. 1997 Oct 15;90(8):3179-86. Blood. 1997. PMID: 9376601 Free article.

10

Anti Candida activity of induced transferrin in mice immunized with inactivated Candida albicans.

Watanabe T, Tanaka H, Nakao N, Mikami T, Suzuki M, Matsumoto T. Watanabe T, et al. Among authors: matsumoto t. Biol Pharm Bull. 1997 Jun;20(6):637-40. doi: 10.1248/bpb.20.637. Biol Pharm Bull. 1997. PMID: 9212981 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,265 results

Search Page

Filters